Skip to main content
The EMBO Journal logoLink to The EMBO Journal
. 2010 Feb 11;29(6):1091–1104. doi: 10.1038/emboj.2010.7

Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival

Matthias Drosten 1, Alma Dhawahir 1, Eleanor Y M Sum 1,*, Jelena Urosevic 1, Carmen G Lechuga 1, Luis M Esteban 2, Esther Castellano 2,, Carmen Guerra 1, Eugenio Santos 2, Mariano Barbacid 1,a
PMCID: PMC2845279  PMID: 20150892

Abstract

We have used mouse embryonic fibroblasts (MEFs) devoid of Ras proteins to illustrate that they are essential for proliferation and migration, but not for survival, at least in these cells. These properties are unique to the Ras subfamily of proteins because ectopic expression of other Ras-like small GTPases, even when constitutively active, could not compensate for the absence of Ras proteins. Only constitutive activation of components of the Raf/Mek/Erk pathway was sufficient to sustain normal proliferation and migration of MEFs devoid of Ras proteins. Activation of the phosphatidylinositol 3-kinase (PI3K)/PTEN/Akt and Ral guanine exchange factor (RalGEF)/Ral pathways, either alone or in combination, failed to induce proliferation or migration of Rasless cells, although they cooperated with Raf/Mek/Erk signalling to reproduce the full response mediated by Ras signalling. In contrast to current hypotheses, Ras signalling did not induce proliferation by inducing expression of D-type Cyclins. Rasless MEFs had normal levels of Cyclin D1/Cdk4 and Cyclin E/Cdk2. However, these complexes were inactive. Inactivation of the pocket proteins or knock down of pRb relieved MEFs from their dependence on Ras signalling to proliferate.

Keywords: cell cycle, PI3K/PTEN/Akt pathway, Raf/Mek/Erk kinases, RalGEF/Ral pathway, small GTPases

Introduction

The Ras family of small GTPases, H-Ras, N-Ras and the two K-Ras isoforms, K-Ras4A and K-Ras4B, are some of the most studied proteins in signal transduction because of their central role in mediating mitogenic signalling and, when mutated, in human cancer. These studies have illustrated how Ras proteins become activated by growth factor receptors and have unveiled those pathways implicated in mediating downstream signalling to their ultimate effectors (reviewed in Malumbres and Barbacid, 2003). Among these pathways, the Raf/Mek/Erk, the phosphatidylinositol 3-kinase (PI3K)/PTEN/Akt and the Ral guanine exchange factor (RalGEF)/Ral pathways have been the best characterized. Accumulated evidence strongly implicates the Raf kinases and their effectors, the Mek and Erk kinases, in mediating cell proliferation or cell differentiation depending on the intensity and duration of the signal (reviewed in Marshall, 1995). The PI3K/Pdk/Akt pathway is supposed to mediate survival signals (reviewed in Cully et al, 2006; Engelman et al, 2006). However, the role of this pathway in mediating Ras signalling is less well characterized, mainly because of the fact that PI3K can be activated by other growth factor receptors through Ras-independent mechanisms. Another group of well-characterized Ras effectors involve the GDP/GTP exchange factors such as Tiam1 and RalGDS. Tiam1 is responsible for activating the Rho/Rac families of small GTPases involved in regulating cell polarity, motility and adhesion (reviewed in Malliri and Collard, 2003). On the other hand, RalGDS is responsible for activation of the Ral proteins primarily involved in membrane trafficking (reviewed in Camonis and White, 2005). Additional downstream effectors include PLCɛ whose activation ultimately results in activation of PKC and release of Ca2+ (reviewed in Bunney and Katan, 2006), AF6 that may also interact with cytoskeletal structures (reviewed in Kooistra et al, 2007) and, more surprisingly, certain proteins that have tumour suppressor activities such as Rin1 (reviewed in Milstein et al, 2007) and RASSF (reviewed in van der Weyden and Adams, 2007). These proteins may be part of feedback loops responsible for downregulation of Ras signalling.

Genetic analysis of Ras signalling pathways has been primarily carried out in lower organisms. In Caenorhabditis elegans and Drosophila melanogaster most phenotypes associated with Ras activity are mediated by the Raf/Mek/Erk pathway (Perrimon, 1994; Rommel and Hafen, 1998; Sternberg and Han, 1998). However, the complexity of Ras signalling may have increased in higher organisms such as mammals. Although endogenous Ras is not necessary for PI3K activity in D. melanogaster (Prober and Edgar, 2001), expression of a PI3K p110α subunit that cannot interact with Ras proteins in mice results in extensive perinatal death because of defective lymphatic vasculature (Gupta et al, 2007). Unfortunately, most genetic data involving Ras proteins are limited to knock out strains. These studies have showed that only K-Ras is essential for embryonic development (Johnson et al, 1997; Koera et al, 1997; Esteban et al, 2001). However, these observations are unlikely to be a consequence of unique signalling properties by K-Ras because expression of H-Ras from the K-Ras locus also leads to normal development (Potenza et al, 2005).

Germ line ablation of Raf kinases has not provided relevant information regarding their role as Ras effectors. C-Raf knockout mice are not viable because of early vascular defects and increased apoptosis without a major effect on cell proliferation (Mikula et al, 2001). B-Raf is only essential for extraembryonic development. Moreover, mouse embryonic fibroblasts (MEFs) lacking B-Raf only show a marginal decrease in cell proliferation (Galabova-Kovacs et al, 2006). Finally, ablation of A-Raf results in postnatal neurological and intestinal abnormalities depending on the genetic background (Pritchard et al, 1996), but has no consequences for cell proliferation (Mercer et al, 2005). The lack of effect on cell proliferation may be a consequence of compensatory activities among the Raf kinases. Indeed, double knockout embryos lacking C-Raf and A-Raf kinases show decreased proliferation rates in spite of sustaining normal levels of Erk phosphorylation (Mercer et al, 2005). The full range of consequences resulting from eliminating the three Raf kinases remains to be determined. Germ line ablation of Mek and Erk kinases has also failed to provide a functional link between these kinases and Ras proteins (Pagès et al, 1999; Bélanger et al, 2003; Fischer et al, 2005; Bissonauth et al, 2006).

In this study, we have analysed the relative contributions of the main Ras signalling pathways to cell proliferation, motility and survival by a genetic approach. To this end, we have generated MEFs carrying null H-Ras and N-Ras alleles along with a floxed K-Ras locus and a knocked-in inducible Cre recombinase (Esteban et al, 2001; Guerra et al, 2003). These MEFs can be rendered Rasless—devoid of Ras proteins—by exposure to 4-hydroxytamoxifen (4OHT) or by infection with adenoviruses expressing a Cre recombinase. Availability of Rasless MEFs has allowed us to analyse the contribution of the main Ras effectors to cell proliferation, motility and survival in the absence of upstream Ras signalling.

Results

Redundant activity of Ras proteins

To determine whether individual Ras genes could drive cell proliferation, primary H-Ras+/+;N-Ras−/−;K-Raslox/lox and H-Ras−/−;N-Ras+/+;K-Raslox/lox MEFs were infected with Adeno-Cre viruses to excise the K-Raslox alleles. Elimination of the floxed sequences resulted in loss of both K-Ras4A and K-Ras4B protein isoforms. Primary H-Ras−/−;N-Ras−/−;K-Raslox/lox MEFs were used for cells expressing only K-Ras proteins. To control for any effects caused by adenoviral infection, H-Ras−/−;N-Ras−/−;K-Raslox/lox MEFs were infected with control Adeno-GFP whereas wild-type MEFs were infected with Adeno-Cre. No effect on cell proliferation was observed in either case (data not shown). Expression of individual Ras proteins was verified by western blot analysis using pan-Ras and H-Ras-specific antibodies (Figure 1A). As illustrated in Figure 1B, expression of individual H-Ras, N-Ras or K-Ras proteins was sufficient to sustain proliferation of primary MEFs. However, K-Ras was considerably more efficient than H-Ras or N-Ras, leading to proliferation rates similar to that of wild-type MEFs. These differences were not because of changes in the levels of expression of the individual Ras proteins because they remained constant independently of the expression of the other isoforms (Figure 1A).

Figure 1.

Figure 1

Proliferative properties of MEFs expressing single Ras loci. (A) Western blot analysis of H-Ras−/−;N-Ras−/−;K-Raslox/lox;RERTert/ert, H-Ras+/+;N-Ras−/−;K-Raslox/lox;RERTert/ert, and H-Ras−/−;N-Ras+/+;K-Raslox/lox;RERTert/ert MEFs 3 days after infection with Adeno-GFP or Adeno-Cre. The pan-Ras antibody recognizes all Ras proteins. GAPDH expression was used as a loading control. (B) Growth curve of primary (passage 1) wild type (solid squares), H-Ras−/−;N-Ras−/−;K-Raslox/lox;RERTert/ert MEFs infected with Adeno-GFP (open squares) and H-Ras+/+;N-Ras−/−;K-Raslox/lox;RERTert/ert MEFs (open triangles) as well as H-Ras−/−;N-Ras+/+;K-Raslox/lox;RERTert/ert MEFs (open circles) infected with Adeno-Cre to remove the conditional K-Raslox alleles. Ras mutant MEFs were derived from two independent embryos. Error bars indicate standard deviation. (C) Immortalization of wild type (solid squares), H-Ras−/−;N-Ras−/−;K-Raslox/lox;RERTert/ert MEFs (open squares), H-Ras+/+;N-Ras−/−;K-Raslox/lox;RERTert/ert MEFs (open triangles) and H-Ras−/−;N-Ras+/+;K-Raslox/lox;RERTert/ert MEFs (open circles) following a 3T3 protocol. H-Ras+/+;N-Ras−/−;K-Raslox/lox;RERTert/ert and H-Ras−/−;N-Ras+/+;K-Raslox/lox;RERTert/ert MEFs were maintained in the presence of 4OHT to achieve excision of the K-Raslox alleles. Ras mutant MEFs were derived from two independent embryos. Error bars indicate standard deviation.

We also examined whether individual Ras proteins could bypass senescence induced by adaptation to culture conditions. When MEFs expressing individual Ras proteins were submitted to a standard 3T3 protocol, all cultures became immortalized albeit with different kinetics (Figure 1C). Although MEFs expressing K-Ras proteins overcame senescence rapidly with the same kinetics as wild-type MEFs, cells expressing either H-Ras or N-Ras alone required additional passages until they acquired an immortal phenotype. These observations indicate that although each member of the Ras family is able to sustain cell proliferation, K-Ras proteins elicit a more robust mitogenic response than H-Ras or N-Ras, at least in MEFs.

Ras proteins are essential for cell proliferation

Next, we examined whether MEFs could proliferate in the absence of all Ras proteins. Primary H-Ras−/−;N-Ras−/−;K-Raslox/lox;RERTnert/ert MEFs, from now on designated as K-Raslox MEFs, were exposed to either Adeno-GFP or Adeno-Cre viruses. Excision of the K-Raslox alleles resulted in complete growth inhibition, indicating that primary MEFs devoid of Ras proteins cannot proliferate (Supplementary Figure 1). Immortal K-Raslox MEFs also ceased proliferation in the absence of Ras proteins (Figure 2A). In this case, we used 4OHT to activate the resident CreERT2 recombinase present in these cells (Guerra et al, 2003). As illustrated in Figure 2A (inset), the conditional K-Raslox alleles became fully excised after 6–9 days in the presence of 4OHT, leading to complete loss of K-Ras expression (Figure 2B). The resulting H-Ras−/−;N-Ras−/−;K-Ras−/−;RERTnert/ert cells will be designated from now on as Rasless MEFs.

Figure 2.

Figure 2

Ras proteins are essential for cell proliferation and migration. (A) Proliferation of immortal K-Raslox MEFs left untreated (open circles) or exposed to 4OHT for the indicated time to eliminate the conditional K-Raslox alleles (solid circles). Error bars indicate standard deviation. Inset depicts a Southern blot analysis showing excision of the conditional K-Raslox alleles (lox) in the presence of 4OHT (knock out, KO). (B) Western blot analysis showing Ras protein expression in K-Raslox cells either left untreated or exposed to 4OHT for 7 or 14 days. Wild-type (WT) MEFs were used as control. Migration of the indicated proteins is shown by arrowheads. Total Erk proteins were used as loading control. (C) Top: bright field microscopic images of K-Raslox MEFs left untreated (K-Raslox) and treated with 4OHT for 14 days (Rasless). Scale bar represents 100 μm. Middle: confocal microscopy images of microtubule organization in K-Raslox MEFs left untreated (K-Raslox) or 14 days after treatment with 4OHT (Rasless) as determined by α-tubulin staining (green) and DAPI counterstaining (blue). Scale bar represents 50 μm. Bottom: confocal microscopy images of actin stress fibres and focal adhesions in K-Raslox MEFs left untreated (K-Raslox) or exposed to 4OHT for 14 days (Rasless) as determined by Phalloidin (green) and Paxillin staining (red). DAPI counterstaining (blue) indicates nuclei. Scale bar represents 50 μm. (D) Migration tracks of individual K-Raslox MEFs left untreated (K-Raslox) (left) or 14 days after treatment with 4OHT (Rasless) (right) as determined by time-lapse microscopy. Migration was tracked for 14 h (n=8).

Rasless MEFs showed significant morphologic alterations including a flat shape with an overall appearance reminiscent of senescent cells (Figure 2C, top). However, Rasless MEFs did not express senescence markers (data not shown), indicating that they remained in a non-proliferative state distinct from senescence. Moreover, Rasless MEFs did not undergo overt apoptosis and could be maintained in culture for several weeks without significant decrease in cell numbers. These observations indicate that Ras proteins are essential for cell proliferation but not survival. Furthermore, they show that none of the other members of the Ras superfamily of proteins can compensate for the lack of Ras signalling to drive cell proliferation.

Ras signalling is essential for cell migration

Loss of Ras proteins severely restricts cell motility and migration. As illustrated in Supplementary Video 1, incubation of K-Raslox MEFs for 5 to 7.5 days in the presence of 4OHT almost completely eliminated mitotic events and prevented cells from migrating around the plate. During this time (60 h), cells appeared to increase in size as a consequence of acquiring a flatter shape. Nevertheless, they retained significant membrane plasticity and showed considerable membrane ruffling activity (Supplementary Video 1). Complete elimination of Ras proteins significantly reduced membrane plasticity and abolished cell migration (Supplementary Video 2). To provide a more quantitative measurement of cell migration, movement of individual MEFs was imaged as indicated in ‘Materials and methods'. Although K-Raslox cells migrated in a random manner, Rasless MEFs were completely unable to migrate (Figure 2D; Supplementary Video 2).

Rasless MEFs also showed major alterations in cytoskeletal structures, such as microtubules and stress fibres (Figure 2C). Moreover, they showed a dramatic increase in the number of focal adhesions as determined by immunostaining for Paxillin, a typical component of focal adhesion structures (Figure 2C). In contrast to normal cells in which focal adhesions are subject to constant reorganization, those present in Rasless MEFs were highly static (Supplementary Video 3). This defect is likely to be the primary cause for the lack of migratory activity of Rasless MEFs. These observations suggest that activation of small Ras-like GTPases involved in membrane ruffling and cell migration may be dependent on active Ras signalling.

The ‘Rasless' state is reversible

To determine whether the proliferative arrest of Rasless cells was reversible, we generated Rasless MEFs ectopically expressing a K-Ras cDNA driven by a Tet-Off system. Cells became fully arrested within 2–4 days after addition of doxycycline (Figure 3A) and acquired the same morphologic properties as Rasless MEFs (Figure 3B). Removal of doxycycline after 10 days or longer resulted in rapid induction of DNA synthesis within 24 h, followed by acquisition of normal morphology and restoration of proliferative and migratory properties (Figure 3B). Similar experiments carried out with an oncogenic K-RasG12V cDNA resulted in a more robust recovery of cell proliferation even before complete restoration of K-RasG12V expression (Figure 3A). These cells also recovered their normal morphology including a reversal of all their cytoskeletal defects and migrated normally on withdrawal from doxycycline (Figure 3C). These findings indicate that the cell cycle arrest, as well as the morphologic and migratory changes induced by loss of Ras signalling, is fully reversible.

Figure 3.

Figure 3

The proliferation and migration defects of Rasless MEFs are reversible. (A) Upper panel: percentages of cells in S phase as indicated by BrdU incorporation in (left) Tet-Off-K-Ras and (right) Tet-Off-K-RasG12V cells after addition and subsequent withdrawal of doxycyline at the indicated time points. Error bars indicate standard deviation. Lower panel: western blot analysis of K-Ras expression at the indicated times. GAPDH expression served as loading control. (B, C) Upper panels: migration defects and cytoskeletal alterations in (B) Tet-Off-K-Ras and (C) Tet-Off-K-RasG12V cells before addition of doxycycline (Day 0), 10 days after treatment with doxycycline (+Dox/Days 0–10) and four additional days after doxycyline withdrawal (−Dox/Days 10–14) as determined by Phalloidin (green) and Paxillin staining (red). DAPI counterstaining (blue) indicates nuclei. Scale bar represents 75 μm. Lower panels: migration tracks from individual (B) Tet-Off-K-Ras and (C) Tet-Off-K-RasG12V cells as determined by time-lapse microscopy. Migration was tracked for 14 h (n=8).

A simple assay to identify that sustain cell proliferation in the absence of Ras proteins

We next developed a simple assay to interrogate whether other signalling molecules could sustain cell proliferation in the absence of Ras proteins. As schematically shown in Figure 4A, K-Raslox MEFs were infected with retroviruses encoding the effector molecule of interest, selected in the presence of the corresponding antibiotic and seeded at limiting dilution (5–10 × 103 cells per 10 cm plate) in the presence or absence of 4OHT. After 2 weeks in culture, proliferating colonies were scored taken as reference parallel cultures not exposed to 4OHT (K-Raslox cells). Colonies >2–3 mm in diameter were isolated to verify loss of Ras expression as well as expression of the effector molecule. Control plates infected with empty retroviruses did not show any colonies, thus, illustrating the robustness of the assay (Figure 4B). These plates contained small groups of cells (<50 cells) that resulted from initial proliferation of K-Raslox MEFs before the activation of the resident Cre recombinase (Figure 4B, upper right).

Figure 4.

Figure 4

(A) Schematic representation of the assay used to identify genes capable of inducing cell proliferation in the absence of Ras proteins. (B) Representative plates from colony formation assays. K-Raslox MEFs were infected with empty retroviruses (control cultures) or retroviruses expressing a K-Ras4B cDNA (effector cultures). After antibiotic selection, cells were plated in the absence (−) or presence (+) of 4OHT and allowed to form colonies for 14 days. The tiny colonies observed in the control Rasless plate consist of small groups of cells (8–32 cells on average) resulting from limited cell proliferation until the K-Raslox alleles are completely excised. None of these cells was able to proliferate for extended periods of time nor on transfer to other plates. Cells were fixed with glutaraldehyde and stained with crystal violet.

As expected, K-Raslox cells infected with retroviruses encoding H-Ras, N-Ras and K-Ras4B led to the formation of colonies in the presence of 4OHT (Supplementary Figure 2; Figure 4B, lower right). Nevertheless, the number of colonies observed never exceeded 30–40% of those expressing the endogenous K-Ras protein (Figure 4B; Supplementary Figure 2A). In contrast, their oncogenic counterparts resulted in colony forming efficiencies of 80–90% of those present in K-Raslox cells (Supplementary Figure 2A). The K-Ras4A isoform, a protein not required for mouse development or homeostasis (Plowman et al, 2003), also sustained proliferation of Rasless cells. However, the efficiency of its oncogenic version, K-Ras4AG12V, was only half of that obtained with the K-Ras4BG12V isoform (Supplementary Figure 2A) in spite of similar levels of expression (Supplementary Figures 2B and 2C). Cells derived from colonies ectopically expressing Ras proteins had the same proliferative and morphologic and migratory properties as wild type or K-Raslox MEFs (data not shown).

Ras proteins are essential for tyrosine protein kinase receptors signalling

It is generally accepted that Ras proteins are key mediators of tyrosine protein kinase receptor signalling. To verify this concept, K-Raslox MEFs were infected with retorviruses expressing the EGF receptor, the related ErbB2 receptor along with its transforming rat isoform, NeuT (Olayioye et al, 2000), and Trk5, a transforming allele of TrkA, the NGF receptor (Coulier et al, 1990). NeuT and Trk5 efficiently transformed NIH3T3 cells. However, they were unable to induce proliferation of K-Raslox MEFs in the presence of 4OHT, indicating that they require Ras proteins to mediate their mitogenic signalling (data not shown). K-Raslox MEFs expressing the wild-type EGFR and ErbB2 receptors also ceased proliferation on ablation of the conditional K-Ras locus in the presence of 4OHT. These observations validate previous studies indicating that tyrosine protein kinase receptors signal through Ras proteins. Moreover, they further illustrate that there are no alternative mechanisms that can compensate for the absence of Ras proteins, at least in MEFs.

Ras-related GTPases cannot compensate for the absence of Ras signalling

We also analysed whether constitutively active forms of Ras-related proteins including R-RasG38V, R-Ras2G23V (also known as TC21), R-Ras3G22V (also known as M-Ras) and E-Ras, a constitutively active Ras-like protein expressed in ES cells, could sustain cell proliferation in the absence of Ras proteins (Movilla et al, 1999; Self et al, 2001; Takahashi et al, 2003). None of these proteins were able to induce proliferation of Rasless cells in spite of robust expression (Figure 5A and B). Similar results were obtained with Rac1N115I and RhoAQ63L (Khosravi-Far et al, 1995), two representative members of the Rho/Rac/Cdc42 protein family (data not shown). Next, we examined whether R-RasG38V, R-Ras2G23V, R-Ras3G22V and E-Ras proteins could activate the Mek/Erk and PI3K/Akt signalling pathways in Rasless MEFs. As shown in Figure 5C, none of these constitutively active small GTPases induced phosphorylation of either Mek or Akt in the absence of Ras. As expected, ectopic expression of H-RasG12V induced robust phosphorylation of both downstream kinases. However, these proteins, with the possible exception of E-Ras, induced Mek phosphorylation in the absence of serum, as long as the cells expressed endogenous K-Ras (Figure 5C). Moreover, R-Ras2G23V and E-Ras proteins, but not R-RasG38V or R-Ras3G22V, efficiently induced phosphorylation of Akt under the same experimental conditions. These observations suggest that constitutively active Ras-like proteins may require the presence of endogenous Ras to exert their biological activity.

Figure 5.

Figure 5

Expression of constitutively active Ras-related small GTPases do not sustain proliferation of Rasless MEFs. (A) Colony-formation assay using K-Raslox MEFs infected with retroviruses expressing the indicated cDNAs. Error bars indicate standard deviation. (B) Western blot analysis showing levels of expression of the proteins encoded by the corresponding cDNAs indicated in (A). GAPDH expression served as a loading control. Migration of the indicated proteins is shown by arrowheads. (C) Western blot analysis of Mek and Akt phosphorylation in K-Raslox MEFs infected with retroviruses encoding the indicated Ras-related proteins incubated in the presence (+) or absence (−) of 4OHT. Indicated cultures were either maintained in the presence of 10% FBS (+) or subjected to serum withdrawal (0.1% FBS for 24 h) (−). Migration of the indicated proteins is shown by arrowheads. Total Mek1 and Akt proteins served as loading controls.

Ras downstream effectors: the Raf kinases

Next, we infected K-Raslox MEFs with H-RasG12V effector mutants known to selectively activate downstream signalling pathways (White et al, 1995; Rodriguez-Viciana et al, 1997). These mutants preferentially activate the Raf/Mek/Erk pathway (D38E mutation), the PI3K/Akt pathway (Y40C) and the RalGDS (E37G) pathway. Only H-RasG12V/D38E sustained cell proliferation in the absence of endogenous Ras proteins albeit with rather low efficiency, about 5% of that observed with H-RasG12V (Figure 6A and B). Similar results were obtained with the corresponding K-Ras4BG12V mutants (data not shown). These observations suggested that the Raf/Mek/Erk pathway might be the primary driver of cell proliferation.

Figure 6.

Figure 6

Constitutive activation of the Raf/Mek/Erk pathway drives proliferation of Rasless MEFs. (A) Colony-formation assay using K-Raslox MEFs infected with retroviruses expressing the indicated cDNAs. p16 shRNA indicates a retrovirus encoding an shRNA directed against p16INK4a-specific sequences. Error bars indicate standard deviation. (B) Western blot analysis showing levels of expression of the indicated H-Ras effector mutant proteins probed with a pan-Ras antibody. Expression of the corresponding H-Ras or K-Ras proteins is indicated by arrowheads. GAPDH expression served as a loading control. (C) Western blot analysis showing expression of the indicated H-RasG12V or RafCAAX proteins in K-Raslox MEFs co-infected with a retrovirus encoding an shRNA directed against p16INK4a-specific sequences (+). Expression of p16INK4a is also indicated. Cells were left untreated (−) or exposed to 4OHT (+). Probing antibodies are indicated in the right panel. Migration of the corresponding proteins is indicated by solid arrowheads. Open arrowheads indicate migration of the endogenous B-RafCAAX and C-RafCAAX proteins. GAPDH expression served as loading control. (D) Western blot analysis showing expression of H-RasG12V, Mek1Q56P and ERK2MEK1LA (EMLA) in K-Raslox MEFs left untreated (−) or exposed (+) to 4OHT. Probing antibodies are indicated in the right panel. Migration of the corresponding proteins is indicated by solid arrowheads. Open arrowheads indicate migration of endogenous Mek1 and Erk1/2 proteins. GAPDH expression served as loading control.

To examine this possibility we expressed individual components the Raf/Mek/Erk pathway in Rasless cells. Expression of unmodified A-Raf, B-Raf or C-Raf proteins failed to induce proliferation of MEFs in the absence of Ras proteins (Figure 6A). These results were not unexpected as one of the main roles proposed for Ras proteins is to bring Raf kinases to the plasma membrane (Wellbrock et al, 2004). To bypass this requirement, we added the K-Ras4B carboxy-terminal domain, including the CAAX motif, to each of the Raf kinases (Leevers et al, 1994). As illustrated in Supplementary Figure 3, these modified proteins activated the Erk pathway with different efficiencies, as determined by their ability to phosphorylate their downstream effectors Mek1 and Erk1/2. Although C-RafCAAX was as efficient as K-RasG12V in phosphorylating Mek1 and Erk1/2, A-RafCAAX and B-BafCAAX failed to induce significant changes in their phosphorylation levels (Supplementary Figure 3).

However, K-Raslox MEFs expressing either A-RafCAAX or B-BafCAAX reproducibly yielded proliferating colonies of Rasless cells (Figure 6A). These colonies, when expanded, showed the same proliferative properties as K-Raslox or wild-type MEFs in spite of lacking Ras proteins (data not shown). These observations indicate that the A-Raf and B-Raf kinases are sufficient to activate those Ras signalling pathways required for cell proliferation in spite of their limited ability to phosphorylate Mek1 and Erk1/2. Moreover, these results further support the hypothesis that the main role of Ras proteins in activating Raf kinases is to bring them to the appropriate location within the plasma membrane. However, expression of A-RafCAAX or B-RafCAAX proteins did not fully reproduce the results observed with Ras oncoproteins. First of all, the percentage of proliferating colonies generated by A-RafCAAX or B-RafCAAX was only 25% of those observed with exogenous H-RasG12V or K-Ras4BG12V (Figure 6A). As their expression levels were similar, these observations suggest that only a percentage of MEFs can proliferate in response to A-RafCAAX or B-RafCAAX. Moreover, when B-RafCAAX was co-expressed with the E1A oncogene, we did not observe foci of transformed cells (data not shown). These results are in agreement with the limited ability of A-RafCAAX and B-RafCAAX to transform NIH3T3 cells (Supplementary Figure 3).

Surprisingly, expression of C-RafCAAX failed to induce proliferation of Rasless cells (Figure 6A). As C-RafCAAX induced high levels of Mek1 and Erk1/2 phosphorylation and was at least 100-fold more efficient than A-RafCAAX or B-RafCAAX in transforming NIH3T3 cells (Supplementary Figure 3), we suspected that C-RafCAAX may induce a stress response that prevented proliferation of Rasless cells. To examine this possibility, we co-infected K-Raslox MEFs with retroviruses encoding C-RafCAAX and an shRNA against p16INK4a, a tumour suppressor known to be implicated in stress responses after C-Raf activation (Lin et al, 1998; Zhu et al, 1998). As illustrated in Figure 6A, C-RafCAAX was as efficient as A-RafCAAX or B-RafCAAX in inducing proliferation of Rasless cells providing that expression of the tumour suppressor p16INK4a was inhibited. Knock down of p16INK4a alone was not sufficient to allow proliferation of Rasless cells (Figure 6A). Moreover, it had no effect on the ability of A-RafCAAX or B-RafCAAX to sustain proliferation of Rasless cells in spite of the fact that the three modified Raf proteins induced similar levels of p16INK4a expression (Supplementary Figure 3A). Thus, it is likely that the stress response induced by C-RafCAAX might be mediated by selective downstream effectors, although it can be ultimately bypassed by knocking down of p16INK4a expression.

Ras downstream effectors: the Mek and Erk kinases

We also examined whether constitutively active forms of the Mek1 and Erk2 kinases elicited cell proliferation in the absence of upstream Ras proteins. K-Raslox cells were infected with a mutant form of human MEK1 in which the Glu56 residue was replaced by proline (Bottorff et al, 1995). Rasless MEFs expressing Mek1Q56P formed colonies of proliferating cells with similar efficiency as those expressing the B-RafCAAX and A-RafCAAX kinases (Figure 6A). Likewise, ERK2MEK1LA (EMLA), a constitutively active Erk2 kinase, also allowed proliferation of Rasless cells with an efficiency similar to Mek1Q56P (Figure 6A). ERK2MEK1LA is a fusion protein between the rat Erk2 and the human Mek1 kinases in which the four lysine residues of the Mek1 nuclear export sequences were mutated to alanine, resulting in constitutive nuclear expression and activation (Robinson et al, 1998). No cell proliferation was observed when we used a similar fusion protein, ERK2MEK1, in which the nuclear export sequences were not mutated (Figure 6A) (Robinson et al, 1998). These observations indicate that all kinases of the Raf/Mek/Erk pathway, if properly activated, can drive cell proliferation in the absence of Ras proteins. Moreover, Rasless MEFs expressing RafCAAX proteins, Mek1Q56P or EMLA showed normal morphologic features and had migratory properties indistinguishable from those of wild type or K-Raslox MEFs (data not shown).

Other Ras downstream effectors: the RalGEF and PI3K pathways

To determine whether activation of the RalGEF and/or the PI3K pathways could contribute to cell proliferation in the absence of Ras proteins, we infected K-Raslox MEFs with retroviruses encoding RalGDS and Rlf, two independent RalGEFs (Wolthuis et al, 1997; Matsubara et al, 1999). Neither of these exchange factors, even when they they carried a modified carboxy-terminal domain (RalGDSCAAX and RlfCAAX), endowed proliferative properties to Rasless MEFs (Figure 7A). Similar results were obtained with their cognate substrate, the small GTPase protein RalA. Neither the wild type nor a constitutively activated isoform (RalAG23V) induced colonies in Rasless cells (Figure 7A). These observations suggest that the RalGEF pathway is not primarily involved in mediating cell proliferation induced by Ras proteins.

Figure 7.

Figure 7

Constitutive activation of the RalGDS and PI3K pathways fails to confer proliferative properties to Rasless cells. (A) Colony-formation assay using K-Raslox MEFs infected with retroviruses expressing the indicated cDNAs or an shRNA directed against PTEN-specific sequences. Error bars indicate standard deviation. (B) Western blot analysis of K-Raslox MEFs infected with the indicated retroviruses. Cells were left untreated (−) or exposed (+) to 4OHT. Probing antibodies are listed in the right panel. Migration of the corresponding proteins is indicated by solid arrowheads. GAPDH expression served as loading control.

We also infected K-Raslox cells with three distinct versions of the p110α subunit of PI3K. They included p110αmyr, the wild-type protein carrying a myristoylation signal at its amino-terminus to facilitate membrane anchoring (Link et al, 2005), a mutated isoform frequently present in human tumours, p110αH1047R (Samuels et al, 2005), and p110αmyr/H1047R, a protein that carried both modifications. None of these proteins was able to confer Rasless MEFs the ability to proliferate (Figure 7A). Unfortunately, lack of reliable antibodies prevented us to show expression of these p110α protein isoforms in Rasless cells. However, ectopic expression of each of these proteins resulted in significant increases in phosphorylation of Akt in Ser473 (Supplementary Figure 4).

To avoid this limitation, we knocked down the tumour suppressor PTEN, a lipid phosphatase that antagonizes PI3K activity (Cully et al, 2006). We used a PTEN shRNA that efficiently inhibited PTEN expression >90% and resulted in robust phosphorylation of Akt (Figure 7B; Supplementary Figure 4). However, K-Raslox MEFs infected with this PTEN shRNA failed to proliferate in the presence of 4OHT (Figure 7A). Thus, indicating that constitutive activation of the PI3K/PTEN/Akt pathway cannot sustain proliferation of MEFs in the absence of Ras proteins.

As illustrated in Supplementary Figure 4, activation of the PI3K/PTEN/Akt pathway also resulted in increased expression of the p16INK4a tumour suppressor. Thus, we examined whether the failure of this pathway as well as the RalGDS/RalA pathway to sustain cell proliferation in the absence for Ras proteins might be due to activation of a p16INK4a-mediated stress response. Ectopic expression of PTEN shRNA and RlfCAAX, with the same p16INK4a shRNA used above to license C-RafCAAX activity, also failed to induce colonies of Rasless cells (Supplementary Figure 5). Similar results were obtained by expressing two representative Ras-like small GTPases, R-Ras2G23V and E-Ras (Supplementary Figure 5).

Cooperation between Ras signalling pathways

To identify potential synergisms between the Raf/Mek/Erk, PI3K/Akt and RalGEF pathways, K-Raslox MEFs were co-infected with retroviruses encoding RlfCAAX and PTEN shRNA. No colony formation could be observed on exposure to 4OHT, indicating that concomitant activation of the RalGDS and PI3K pathways cannot compensate for the lack of activation of the Raf/Mek/Erk kinases (Figure 7A). Next, we interrogated whether these pathways could cooperate with the Raf/Mek/Erk pathway. K-Raslox MEFs were co-infected with retroviruses encoding Mek1Q56P with either RlfCAAX or PTEN shRNA. No significant cooperation could be observed (Figure 7A). However, when we co-expressed Mek1Q56P, RlfCAAX and PTEN shRNA, the percentage of proliferating Rasless colonies were significantly increased to levels similar to those observed with retroviruses encoding the constitutively activated H-RasG12V oncoprotein (Figure 7).

Ras signalling and the cell cycle

It is widely accepted that one of the ultimate targets of Ras signalling is to induce expression of D-type Cyclins to activate Cdk4 and Cdk6. In turn, these complexes phosphorylate and inactivate the pocket proteins to license initiation of the cell cycle (Aktas et al, 1997; Coleman et al, 2004). Availability of Rasless cells has allowed us to test this hypothesis by genetic means. Surprisingly, Rasless cells are not devoid of D-type Cyclins. Instead, they showed increased levels of Cyclin D1, the main D-type Cyclin expressed in MEFs (Figure 8A). Cyclin E1, another Cyclin presumably involved in the early phases of the cell cycle, was still present in Rasless MEFs (Figure 8A). In addition, Cyclin D1/Cdk4 and Cyclin E1/Cdk2 complexes were present at normal levels in Rasless MEFs (Figure 8B). However, these complexes are not capable of phosphorylating pRb at their cognate residues Ser807 and Ser811 (Figure 8C). Analysis of the in vitro kinase activities of these complexes obtained from Rasless cells showed that they were less efficient in phosphorylating recombinant pRb protein in vitro than the corresponding complexes obtained from proliferating K-Raslox MEFs cells than in control cells (Supplementary Figure 6). Other cell cycle-related complexes were not taken into consideration as Cdk1 is absent from Rasless MEFs (Supplementary Figure 6). These observations indicate that Ras proteins are dispensable for the regulation of Cyclin D1 and Cyclin E1 expression. However, the Cyclin D1/Cdk4 and Cyclin E1/Cdk2 complexes present in these cells are not active and, thus, cannot inactivate the pocket proteins. Failure to inactivate the pocket proteins, and hence to drive cells through G1 explains the lack of expression of Cyclin A2, Cyclin B1 and their cognate partner Cdk1 in Rasless cells (Figure 8A; Supplementary Figure 6).

Figure 8.

Figure 8

Role of cell cycle regulators on the proliferative properties of Rasless cells. (A) Expression levels of cell cycle Cyclins in K-Raslox MEFs exposed to 4OHT for the indicated times as determined by western blot analysis. Loss of K-Ras expression is illustrated in the upper panel. α-Tubulin expression served as loading control. (B) Identification of Cyclin D1/Cdk4 (upper panel) and Cyclin E1/Cdk2 (lower panel) complexes by immunoprecipitation with antibodies against Cyclin D1 (upper panel) and Cyclin E (lower panel) in K-Raslox and Rasless cells; 1/16th of the whole cell extract (WCE) used for immunoprecipitation of K-Raslox MEFs was loaded as a control. Additional controls included mock (M) immunoprecipitates obtained from K-Raslox MEFs by incubating without primary antibody and 1/16th of WCE from Cdk2−/−;Cdk4−/− MEFs (Cdk2/4dKO). (C) Analysis of pRb phosphorylation in K-Raslox and Rasless cells by western blot analysis using antibodies against PSer807/811-phosphorylated pRb. Total pRb was used as a loading control. (D) Colony-formation assay using K-Raslox MEFs infected with retroviruses expressing the indicated cDNAs or an shRNA directed against pRb-specific sequences. Error bars indicate standard deviation. (E) Upper panels: western blot analysis of Cyclin D1, Cyclin E1, Cyclin A2 and Cyclin B1 expression in K-Raslox MEFs infected with an empty vector or with retroviruses encoding wild-type Cyclin D1, Cyclin D1T286A, Cyclin E1, Cyclin A2 and Cyclin B1. Migration of the indicated proteins is shown by arrowheads. α-Tubulin (T) or GAPDH (G) expression served as loading controls. Lower panels: quantification of protein expression levels from at least two independent experiments.

To further test whether inhibition of the pocket proteins is one of the ultimate outcomes of Ras signalling to drive cell proliferation, we inactivated the pocket proteins in these cells by two independent approaches. First, we expressed a fragment of the SV40 large T antigen (T121) known to inhibit all three members of the Rb family (Saenz Robles et al, 1994). As shown in Figure 8D, Rasless cells expressing T121 proliferated efficiently. Similar results were obtained using an shRNA specific for the pRb protein (Figure 8D). These observations indicated that MEFs can proliferate in the absence fo Rass proteins providing that the pocket proteins are inhibited. Moreover, they suggest that in these cells pRb is the main effector of Ras signalling (Coleman et al, 2004). Nevertheless, the levels of proliferating colonies in Rasless cells expressing T121 and pRb shRNA were considerable lower than in wild-type cells or in Rasless cells ectopically expressing the constitutively activated H-RasG12V oncoprotein. Thus, indicating that other Ras-mediated signalling pathways are likely to contribute to drive the cell cycle.

Ectopic expression of Cyclin D1 resulting in a two-fold increase in its levels of expression also failed to sustain proliferation of Rasless cells (Figure 8D and E). Similar results were obtained with the G2/M Cyclins, Cyclin A2 and Cyclin B1, suggesting that Rasless cells are blocked in G1 (Figure 8D and E). This hypothesis was further supported by expressing a non-degradable mutant of Cyclin D1, Cyclin D1T286A (Diehl et al, 1998). Overexpression (7–8-fold) of this protein in Rasless cells allowed proliferation of these cells with the same efficiency as inactivation/knockdown of pRb (Figure 8D and E; Supplementary Figure 6). Thus, suggesting that overloading the cell nucleus with large amounts of Cyclin D1 could activate the resident Cdk4/6 kinases, leading to phosphorylation and inactivation of pRb.

Discussion

Selective ablation of the three Ras loci in MEFs has shown that each Ras protein is capable of sustaining proliferation of MEFs in culture in the absence of the other two. Moreover, MEFs expressing individual Ras genes became immortal on continuous passage in culture. Nevertheless, K-Ras proteins (K-Ras4B and K-Ras4A) were more efficient to drive cell proliferation and immortalization than H-Ras or N-Ras. Indeed, cells expressing K-Ras proteins alone proliferated and bypassed senescence as efficiently as wild-type MEFs. These differences are not because of changes in expression levels as ablation of individual Ras proteins did not affect expression of the other members of the family, thus suggesting that they are independently regulated. Expression of chimaeric Ras proteins carrying distinct combinations of effector and carboxy-terminal domains in Rasless cells should provide relevant information as of whether the differential properties of the K-Ras proteins are due to their interaction with downstream effectors or to their distinct subcellular localization (Buday and Downward, 2008; Omerovic and Prior, 2009).

Earlier studies using anti-Ras antibodies (Mulcahy et al, 1985) and Ras dominant negative mutants (Feig and Cooper, 1988) have suggested that Ras proteins are essential for cell proliferation. Our results, involving ablation of the three Ras genes provide definitive genetic proof for these earlier observations. Our observations indicate that the cell cycle arrest because of ablation of Ras proteins is reversible and does not elicit an apoptotic or a senescence response. In addition, our results showed that loss of Ras proteins induced major alterations in cytoskeletal structures, such as microtubules and stress fibres resulting in a significant increase in the number of focal adhesions along with a reduced turnover. As a consequence, Rasless MEFs showed a very flat morphology, have reduced membrane plasticity and are not able to migrate. Thus, Ras signalling is also essential for cell migration, at least in rodent fibroblasts.

Our results provide genetic evidence that none of the members of the large Ras superfamily of small GTPases can compensate for the absence of Ras proteins. Ectopic expression of constitutively activated small GTPases known to induce malignant transformation of rodent fibroblasts, such as the R-Ras family and E-Ras, also failed to induce proliferation in the absence of Ras proteins. Interestingly, these constitutively active GTPases required the presence of Ras proteins to activate the Raf/Mek/Erk pathway. This requirement is unlikely to be mediated by Ras-dependent activation of exchange factors, such as Tiam1 or RalGDS, as the small GTPases are already constitutively active. It is possible that Ras proteins are required to allow specific effectors for the R-Ras/E-Ras GTPases to either phosphorylate Mek and Erk kinases or prevent their dephosphorylation by negative regulators (Rodriguez-Viciana et al, 2006).

Among the best-characterized Ras effector pathways, only the Ras/Mek/Erk pathway was capable of sustaining cell proliferation in the absence of Ras proteins. Interestingly, the only requirement for the Raf kinases to induce proliferation of Rasless cells was to be attached to the plasma membrane. These observations provide further support to the concept that the main role of Ras proteins to activate the Ras/Mek/Erk pathway is to bring the Raf kinases to the membrane (Wellbrock et al, 2004). Each of the Raf kinases induced proliferation of Rasless cells to similar levels, independently of their potential to activate Mek kinases or to transform NIH3T3 cells. However, C-RafCAAX, the most efficient Raf isoform in activating Mek and Erk proteins and in inducing tranformation of NIH3T3 cells, elicited a stress response that could be overcome by knocking down p16INK4a expression. Interestingly, all RafCAAX proteins, as well as the H-RasG12V and K-RasG12V oncoproteins, induced similar levels of p16INK4a expression. Thus, suggesting that the stress response induced by C-RafCAAX is mediated by selective downstream effectors.

Constitutively, active forms of Mek1 and Erk2 kinases were as efficient as the membrane-bound Raf kinases to induce cell proliferation in the absence of Ras proteins. These observations provide further support to the concept that the Raf/Mek/Erk pathway is primarily a linear signalling pathway in which activation of each kinase family has similar biological readouts (Roberts and Der, 2007). Thus, the evolutionary requirement for the linear activation of these families of kinases must stem from activities other than basic cell proliferation or by inducing proliferation in other cell types.

Genetic interrogation of the PI3K and RalGEF pathways in Rasless cells, either alone or in combination, indicates that they cannot sustain cell proliferation in the absence of Ras proteins, at least in rodent fibroblasts. Whether these pathways could sustain proliferation of other cell types in the absence of Raf/Mek/Erk signalling is currently under investigation (Gupta et al, 2007). However, activation of the PI3K and RalGEF pathways complemented Mek1-mediated signalling to levels similar to those obtained expressing constitutively active Ras proteins. Thus, reconstitution of the full proliferative response mediated by Ras signalling requires cooperation by the three main Ras effector pathways, PI3K, RalGEF and Raf/Mek/Erk. Interrogation of other cellular functions beyond cell proliferation should help to better ascertain the individual contributions of each of these pathways in mediating Ras signalling.

The growth arrest characteristic of Rasless MEFs is fully reversible. To what extent the cell cycle arrest induced by loss of Ras protein expression in the presence of serum is similar to the quiescence (G0) reached by the absence of serum is currently unknown. Downregulation of a single pocket protein, pRb, was sufficient to confer proliferative properties to cells devoid of Ras proteins. Thus, our results support the concept that the ultimate readout of Ras signalling is inactivation of the pocket proteins (Coleman et al, 2004). However, our results do not support the widely accepted hypothesis that Ras proteins induce initiation of the cell cycle by inducing expression of D-type Cyclins. Indeed, growth-arrested Rasless cells have even increased levels of Cyclin D1 and normal levels of Cyclin D-Cdk4/6 or Cyclin E-Cdk2 complexes. However, these complexes do not have kinase activity in vitro and are unable to phosphorylate pRb in vivo. Thus, Ras signalling results in initiation of the cell cycle by activating pre-existing Cyclin D-Cdk4/6 or Cyclin E-Cdk2 complexes rather than by inducing expression of D-type Cyclins.

It is likely that the lack of activity of these Cyclin/Cdk complexes is due to the presence of a cell cycle inhibitor rather than to activation of other effectors. The ability of a non-degradable mutant of Cyclin D1 to induced proliferation of Rasless cells supports this concept. However, such inhibitor is unlikely to be the p16INK4a tumour suppressor as downregulation of p16INK4a did not restore proliferation of Rasless MEFs. Recent results from our laboratory suggest that the cell cycle inhibitor p21Cip1 might be involved in preventing cell proliferation in the absence of Ras proteins (unpublished observations).

In summary, genetic interrogation of Ras signalling has confirmed some of the basic tenants of Ras biology. However, our observations have raised important issues about other widely accepted hypotheses regarding Ras signalling such as their role in inducing Cyclin D expression or in sustaining cell survival. Ablation of Ras proteins in more specialized cell types such as keratinocytes, haematopoietic cells or neurons should provide a better and wider picture of the biological role of these key signalling molecules in mammalian cells.

Materials and methods

Cell culture assays

Wild type, H-Ras−/−;N-Ras−/−;K-Raslox/lox;RERTert/ert, H-Ras+/+;N-Ras−/−;K-Raslox/lox;RERTert/ert, and H-Ras−/−;N-Ras+/+;K-Raslox/lox;RERTert/ert MEFs were isolated from E13. 5 embryos of the corresponding genotype and frozen as primary cultures or immortalized following a standard 3T3 protocol, as described earlier (Malumbres et al, 2004). Other cell lines including NIH3T3 cells and the retroviral packaging Phoenix-Eco cells (ATCC) have been described (Martín et al, 2005). Low passage (p12–15), immortal H-Ras−/−;N-Ras−/−;K-Raslox/lox,RERTert/ert MEFs were infected with retroviral supernatants and selected with the appropriate antibiotic as described earlier (Martín et al, 2005). Resistant cells were seeded in equal cell numbers (5–10 × 103) in the absence or presence of 4OHT (Sigma, 600 nM). Cells were allowed to form colonies for 2 weeks. Plates were fixed with 1% glutaraldehyde (Sigma), stained with crystal violet (Merck) and colonies >2 mm in diameter scored. When needed, representative colonies were picked and expanded for further analysis.

Protein analysis

For western blot analysis, cells were lysed as described earlier (Sotillo et al, 2001). Usually, 40 μg of total protein extract was resolved by SDS–PAGE and transferred to nitrocellulose membranes. Probing antibodies are described in Supplementary data. For immunoprecipitation, antibodies against Cyclin D1 (Ab-4, Neomarkers) or Cyclin E1 (Abcam) were used. Kinase assays were performed as described (Malumbres et al, 2004). Recombinant pRb used as a substrate in kinase assays was obtained from Santa Cruz Biotechnology (Rb 769).

Cell migration assay and time-lapse videomicroscopy

To trace the movement of individual MEFs, cells were seeded on fibronectin-coated plates and imaged with a DeltaVision Microscope (Stress Photonics) for 14 h at 1 frame/5 min and manually tracked with Metamorph (Molecular Devices). For focal adhesion dynamics, cells were transfected with a plasmid encoding DsRed-Zyxin using lipofectamin (Invitrogen) and imaged with an SP5-MP confocal microscope (Leica) for 45 min at 2 frames/min. To visualize the cell cycle arrest in live MEFs, cells were initially treated with 4OHT for 5 days and then imaged with an SP2 confocal microscope (Leica) for 60 h at 1 frame/5 min.

Confocal microscopy

For confocal microscopy, cells were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100. Primary antibodies for Cyclin D1 (Clone DCS-6, Neomarkers), α-tubulin (DM1a, Sigma) and Paxillin (clone 5H11, Upstate) were incubated in PBS with 3% BSA. To stain actin fibres, Alexa Fluor 488 Phalloidin (Invitrogen) was directly added to the primary antibody mixture. Alexa Fluor 488- or Alexa Fluor 594-conjugated secondary antibodies (Invitrogen) were used to detect the indicated proteins. Cells were counterstained with DAPI (Sigma).

Supplementary Material

Supplementary data
emboj20107s1.pdf (2.8MB, pdf)
Supplementary Video 1
Download video file (7.9MB, mov)
Supplementary Video 2
Download video file (4.2MB, mov)
Supplementary Video 3
Download video file (1.2MB, mov)
Review Process File
emboj20107s5.pdf (330.7KB, pdf)

Acknowledgments

We thank R Bernards, A Carnero, M Cobb, P Crespo, N Hynes, M Malumbres, R Marais, I Perez de Castro, M Perez-Moreno, U Rapp, M Serrano and T van Dyke for providing reagents. We also thank Mirna Perez-Moreno, David Santamaría and Marcos Malumbres for helpful discussions, Marta San Roman and Raquel Villar for expert technical assistance and Diego Megias for help in confocal and time-lapse microscopy. This work was supported by grants from the Ministry of Science and Innovation (MICINN) (SAF2006-11773 and Consolider-Ingenio 2010, CSD2007-00017), the Comunidad Autónoma de Madrid (S-BIO-0283-2006) and the 7th Framework Programme (CHEMORES LSHG-CT-2007-037665) to MB, by grants from the Junta de Castilla y León (SA044A08 and GR93) and the Instituto de Salud Carlos III (ISCIII) (FIS PI021570) to ES and by institutional support from the RTICC (RD06/0020/000) and Acción Transversal en Cáncer 2008 from the ISCIII (also to ES). MD was supported by postdoctoral fellowships from the Ernst Schering Foundation and the Deutsche Forschungsgemeinschaft. EYMS was a recipient of a CJ Martin postdoctoral fellowship from the National Health and Medical Research Council (Australia).

Footnotes

The authors declare that they have no conflict of interest.

References

  1. Aktas H, Cai H, Cooper GM (1997) Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 17: 3850–3857 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bélanger LF, Roy S, Tremblay M, Brott B, Steff AM, Mourad W, Hugo P, Erikson R, Charron J (2003) Mek2 is dispensable for mouse growth and development. Mol Cell Biol 23: 4778–4787 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bissonauth V, Roy S, Gravel M, Guillemette S, Charron J (2006) Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm placentogenesis. Development 133: 3429–3440 [DOI] [PubMed] [Google Scholar]
  4. Bottorff D, Stang S, Agellon S, Stone JC (1995) RAS signaling is abnormal in a c-raf1 MEK1 double mutant. Mol Cell Biol 15: 5113–5122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buday L, Downward J (2008) Many faces of Ras activation. Biochim Biophys Acta 1786: 178–187 [DOI] [PubMed] [Google Scholar]
  6. Bunney T, Katan M (2006) Phospholipase C epsilon: linking second messengers and small GTPases. Trends Cell Biol 16: 640–648 [DOI] [PubMed] [Google Scholar]
  7. Camonis JH, White MA (2005) Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol 15: 327–332 [DOI] [PubMed] [Google Scholar]
  8. Coleman ML, Marshall CJ, Olsen MF (2004) RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol 5: 355–366 [DOI] [PubMed] [Google Scholar]
  9. Coulier F, Kumar R, Ernst M, Klein R, Martin-Zanca D, Barbacid M (1990) Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol Cell Biol 10: 4202–4210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cully M, You H, Levine AJ, Mak TW (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184–192 [DOI] [PubMed] [Google Scholar]
  11. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499–3511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606–619 [DOI] [PubMed] [Google Scholar]
  13. Esteban LM, Vicario-Abejón C, Fernández-Salguero P, Fernández-Medarde A, Swaminathan N, Yienger K, Lopez E, Malumbres M, McKay R, Ward JM, Pellicer A, Santos E (2001) Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444–1452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Feig LA, Cooper GM (1988) Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235–3243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fischer AM, Katayama CD, Pagès G, Pouysségur J, Hedrick SM (2005) The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23: 431–443 [DOI] [PubMed] [Google Scholar]
  16. Galabova-Kovacs G, Matzen D, Piazzolla D, Meissl K, Plyushch T, Chen AP, Silva A, Baccarini M (2006) Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci USA 103: 1325–1330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guerra C, Mijimolle N, Dhawahir A, Dubus P, Barradas M, Serrano M, Campuzano V, Barbacid M (2003) Tumor induction by an endogenous K-Ras oncogene is highly dependend on cellular context. Cancer Cell 4: 111–120 [DOI] [PubMed] [Google Scholar]
  18. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129: 957–968 [DOI] [PubMed] [Google Scholar]
  19. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11: 2468–2481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ (1995) Activation of Rac1, RhoA and mitogen-activated protein kinase is required for Ras transformation. Mol Cell Biol 15: 6443–6453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T, Otani H, Aiba A, Katsuki M (1997) K-ras is essential for the development of the mouse embryo. Oncogene 15: 1151–1159 [DOI] [PubMed] [Google Scholar]
  22. Kooistra MR, Dubé N, Bos JL (2007) Rap1: a key regulator in cell-cell junction formation. J Cell Sci 120: 17–22 [DOI] [PubMed] [Google Scholar]
  23. Leevers SJ, Paterson HF, Marshall CJ (1994) Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411–414 [DOI] [PubMed] [Google Scholar]
  24. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW (1998) Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12: 3008–3019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Link W, Rosada A, Fominaya J, Thomas JE, Carnero A (2005) Membrane localization of all class I PI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt. J Cell Biochem 95: 979–989 [DOI] [PubMed] [Google Scholar]
  26. Malliri A, Collard JG (2003) Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol 15: 583–589 [DOI] [PubMed] [Google Scholar]
  27. Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459–465 [DOI] [PubMed] [Google Scholar]
  28. Malumbres M, Sotillo R, Santamaría D, Galán J, Cerezo A, Ortega S, Dubus P, Barbacid M (2004) Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493–504 [DOI] [PubMed] [Google Scholar]
  29. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185 [DOI] [PubMed] [Google Scholar]
  30. Martín A, Odajima J, Hunt SL, Dubus P, Ortega S, Malumbres M, Barbacid M (2005) Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1. Cancer Cell 7: 591–598 [DOI] [PubMed] [Google Scholar]
  31. Matsubara K, Kishida S, Matsuura Y, Kitayama H, Noda M, Kikuchi A (1999) Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation. Oncogene 18: 1303–1312 [DOI] [PubMed] [Google Scholar]
  32. Mercer K, Giblett S, Oakden A, Brown J, Marais R, Pritchard C (2005) A-Raf and Raf-1 work together to influence transient ERK phosphorylation and G1/S cell cycle progression. Oncogene 24: 5207–5217 [DOI] [PubMed] [Google Scholar]
  33. Mikula M, Schreiber M, Husak Z, Kucerova L, Rüth J, Wieser R, Zatloukal K, Beug H, Wagner EF, Baccarini M (2001) Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 20: 1952–1962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Milstein M, Mooser CK, Hu H, Fejzo M, Slamon D, Goodglick L, Dry S, Colicelli J (2007) RIN1 is a breast tumor suppressor gene. Cancer Res 67: 11510–11516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Movilla N, Crespo P, Bustelo XR (1999) Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene 18: 5860–5869 [DOI] [PubMed] [Google Scholar]
  36. Mulcahy LS, Smith MR, Stacey DW (1985) Requirement for ras proto-oncogene function during serum stimulated growth of NIH3T3 cells. Nature 313: 241–423 [DOI] [PubMed] [Google Scholar]
  37. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159–3167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Omerovic J, Prior IA (2009) Compartmentalized signalling: Ras proteins and signaling nanoclusters. FEBS J 276: 1817–1825 [DOI] [PubMed] [Google Scholar]
  39. Pagès G, Guérin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P, Pouysségur J (1999) Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286: 1374–1377 [DOI] [PubMed] [Google Scholar]
  40. Perrimon N (1994) Signalling pathways initiated by receptor tyrosine kinases in Drosophila. Curr Opin Cell Biol 6: 260–266 [DOI] [PubMed] [Google Scholar]
  41. Plowman SJ, Williamson DJ, O'Sullivan MJ, Doig J, Ritchie AM, Harrison DJ, Melton DW, Arends MJ, Hooper ML, Patek CE (2003) While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol Cell Biol 23: 9245–9250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Potenza N, Vecchione C, Notte A, De Rienzo A, Rosica A, Bauer L, Affuso A, De Felice M, Russo T, Poulet R, Cifelli G, De Vita G, Lembo G, Di Lauro R (2005) Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep 6: 432–437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pritchard CA, Bolin L, Slattery R, Murray R, McMahon M (1996) Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol 6: 614–617 [DOI] [PubMed] [Google Scholar]
  44. Prober DA, Edgar BA (2001) Growth regulation by oncogenes—new insights from model organisms. Curr Opin Genet Dev 11: 19–26 [DOI] [PubMed] [Google Scholar]
  45. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291–3310 [DOI] [PubMed] [Google Scholar]
  46. Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH (1998) A constitutively active and nuclear form of MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8: 1141–1150 [DOI] [PubMed] [Google Scholar]
  47. Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 22: 217–230 [DOI] [PubMed] [Google Scholar]
  48. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89: 457–467 [DOI] [PubMed] [Google Scholar]
  49. Rommel C, Hafen E (1998) Ras—a versatile cellular switch. Curr Opin Genet Dev 8: 412–418 [DOI] [PubMed] [Google Scholar]
  50. Saenz Robles MT, Symonds H, Chen J, Van Dyke T (1994) Induction versus progression of brain tumor development: differential function for the pRB and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol 14: 2686–2698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Samuels Y, Diaz LA Jr, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2005) Mutant PIK3C promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561–573 [DOI] [PubMed] [Google Scholar]
  52. Self AJ, Caron E, Paterson HF, Hall A (2001) Analysis of R-Ras signalling pathways. J Cell Sci 114: 1357–1366 [DOI] [PubMed] [Google Scholar]
  53. Sotillo R, Dubus P, Martín J, de la Cueva E, Ortega S, Malumbres M, Barbacid M (2001) Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitiors. EMBO J 20: 6637–6647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Sternberg PW, Han M (1998) Genetics of RAS signaling in C. elegans. Trends Genet 14: 466–472 [DOI] [PubMed] [Google Scholar]
  55. Takahashi K, Mitsui K, Yamanaka S (2003) Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423: 541–545 [DOI] [PubMed] [Google Scholar]
  56. van der Weyden L, Adams DJ (2007) The Ras-association domain family (RASSF) members and their role in tumorigenesis. Biochim Biophys Acta 1776: 58–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wellbrock C, Karasarides M, Marais R (2004) The RAF proteins take center stage. Nat Rev Mol Cell Biol 5: 875–885 [DOI] [PubMed] [Google Scholar]
  58. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH (1995) Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541 [DOI] [PubMed] [Google Scholar]
  59. Wolthuis RM, de Ruiter MD, Cool RH, Bos JL (1997) Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J 16: 6748–6761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Zhu J, Woods D, McMahon M, Bishop JM (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 12: 2997–3007 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data
emboj20107s1.pdf (2.8MB, pdf)
Supplementary Video 1
Download video file (7.9MB, mov)
Supplementary Video 2
Download video file (4.2MB, mov)
Supplementary Video 3
Download video file (1.2MB, mov)
Review Process File
emboj20107s5.pdf (330.7KB, pdf)

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES